PetLife Pharmaceuticals Launches New Website

PetLife Pharmaceuticals, Inc. (OTCQB: PTLF) (the “Company,” “PetLife”), a developer of a new generation of high-potency veterinary cancer medications and nutraceuticals for pets, announced its new Website,

PetLife has launched its new Website to incorporate the Company’s recent announcement of its patent filings in the United States and India, as well as more information on the Company’s short- and long-term plans, including the establishment of the PetLife Scorpion Ranch™ for Blue Scorpions, and the addition of Dr. Geoff’s by PetLife™.

Dr. Ralph T. Salvagno, CEO of PetLife, stated, “Our Website will continue to evolve as activities, specifically the PetLife Scorpion Ranch™, are brought online. We will also be making announcements on the availability to consumers for our premier line of pet food.”

The new Website also provides for the biographies of the management team, including Dr. Salvagno, Dr. Vivekananda Ramana, our Chief Medical Officer, and Dr. Joel Beth Mitchell-Navratik, our Director of Veterinary Affairs. Dr. Ramana and his research team are working closely with Dr. Salvagno with our United States Food and Drug Administration (“FDA”) application. Dr. Ramana has successfully registered 25 compounds with the FDA. Dr. Mitchell-Navratik, a veterinarian, is a key member of our scientific team.

About PetLife Pharmaceuticals, Inc.

PetLife Pharmaceuticals, Inc. (PTLF) ( is a registered U.S. Veterinary Pharmaceutical company. PetLife's mission is to bring its new, non-toxic, bioactive nutraceuticals and prescription medications to the world of veterinary oncology with the ultimate goal of preventing cancer and extending the life of pets suffering from cancer while improving their quality of life. The Company’s first product, Vitalzul™, is currently in testing. Vitalzul’s™ active ingredients have been shown to have activity against several different cancer cell lines. In the U.S. alone, consumer spending on domestic companion animals reached over $60 billion in 2015, with over $29 billion spent on veterinary care and medications. PetLifes’s acquired brand, Dr. Geoff’s by PetLife™, will launch in 2017. PetLife Scorpion Ranch™ will break ground in 2017. PetLife anticipates incorporating Vitalzul™ in a new and advanced therapeutic pet food line in 2019.

Forward looking statement:

This press release contains certain "forward-looking statements," as defined in the United States PSLR Act of 1995, that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. The economic, competitive, governmental, technological and other factors identified in the Company's previous filings with the Securities and Exchange Commission may cause actual results or events to differ materially from those described in the forward-looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Press Contact

Clifford Price
844-473-8543 ext. 701

Source: PetLife Pharmaceuticals, Inc.


Categories: Pharmaceuticals and Biotech, Pets, Veterinary

Tags: Cancer, Cat, Dog, FDA, Pet, Scorpion, Venom, Veterinary

About Petlife Pharmaceuticals

View Website

PetLife Pharmaceuticals, Inc. (PTLF) ( is a registered U.S. Veterinary Pharmaceutical company.

Petlife Pharmaceuticals
38 West Main Street
Hancock, MD 21750
United States